BE629171A - - Google Patents

Info

Publication number
BE629171A
BE629171A BE629171A BE629171A BE629171A BE 629171 A BE629171 A BE 629171A BE 629171 A BE629171 A BE 629171A BE 629171 A BE629171 A BE 629171A BE 629171 A BE629171 A BE 629171A
Authority
BE
Belgium
Application number
BE629171A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US177169A external-priority patent/US3072641A/en
Priority claimed from US177169A external-priority patent/US3072639A/en
Priority claimed from US177169A external-priority patent/US3072640A/en
Priority claimed from US177169A external-priority patent/US3072642A/en
Application filed filed Critical
Publication of BE629171A publication Critical patent/BE629171A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0042Nitrogen only
    • C07J71/0047Nitrogen only at position 2(3)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE629171A 1962-03-05 1963-03-04 BE629171A (US08088918-20120103-C00204.png)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US177169A US3072641A (en) 1962-03-05 1962-03-05 16-oxygenated-4-pregneno-[3, 2-c] pyrazoles and process of preparing them
US177169A US3072639A (en) 1962-03-05 1962-03-05 16-oxygenated-4-pregneno-[3, 2-c] pyrazoles and process of preparing them
US177169A US3072640A (en) 1962-03-05 1962-03-05 16-oxygenated-4-pregneno-[3, 2-c] pyrazoles and process of preparing them
US177169A US3072642A (en) 1962-03-05 1962-03-05 16-oxygenated-4-pregneno-[3, 2-c] pyrazoles and process of preparing them

Publications (1)

Publication Number Publication Date
BE629171A true BE629171A (US08088918-20120103-C00204.png) 1963-09-04

Family

ID=27497228

Family Applications (1)

Application Number Title Priority Date Filing Date
BE629171A BE629171A (US08088918-20120103-C00204.png) 1962-03-05 1963-03-04

Country Status (7)

Country Link
BE (1) BE629171A (US08088918-20120103-C00204.png)
BR (1) BR6347344D0 (US08088918-20120103-C00204.png)
CH (1) CH454843A (US08088918-20120103-C00204.png)
DE (1) DE1468243A1 (US08088918-20120103-C00204.png)
FI (1) FI40461B (US08088918-20120103-C00204.png)
FR (1) FR3086M (US08088918-20120103-C00204.png)
GB (1) GB1030304A (US08088918-20120103-C00204.png)

Also Published As

Publication number Publication date
FR3086M (fr) 1965-02-26
FI40461B (US08088918-20120103-C00204.png) 1968-10-31
BR6347344D0 (pt) 1973-08-28
GB1030304A (en) 1966-05-18
CH454843A (de) 1968-04-30
DE1468243A1 (de) 1969-07-24

Similar Documents

Publication Publication Date Title
FI40461B (US08088918-20120103-C00204.png)
BE614757A (US08088918-20120103-C00204.png)
BE632620A (US08088918-20120103-C00204.png)
AU269855A (US08088918-20120103-C00204.png)
AU480751A (US08088918-20120103-C00204.png)
BE380301A (US08088918-20120103-C00204.png)
BE634968A (US08088918-20120103-C00204.png)
BE489310A (US08088918-20120103-C00204.png)
BE538252A (US08088918-20120103-C00204.png)
BE538831A (US08088918-20120103-C00204.png)
BE541929A (US08088918-20120103-C00204.png)
BE553896A (US08088918-20120103-C00204.png)
BE559145A (US08088918-20120103-C00204.png)
BE586180A (US08088918-20120103-C00204.png)
BE592434A (US08088918-20120103-C00204.png)
BE599783A (US08088918-20120103-C00204.png)
BE604335A (US08088918-20120103-C00204.png)
BE608197A (US08088918-20120103-C00204.png)
BE609543A (US08088918-20120103-C00204.png)
BE612190A (US08088918-20120103-C00204.png)
BE612311A (US08088918-20120103-C00204.png)
BE612464A (US08088918-20120103-C00204.png)
BE612847A (US08088918-20120103-C00204.png)
BE612926A (US08088918-20120103-C00204.png)
BE613108A (US08088918-20120103-C00204.png)